Outcomes of a Pre-operative Exercise Programme for Live Donor and Recipient Kidney Transplant Patients
OPERATe
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a pre-operative outpatient exercise programme, monitored by a smart wearable device is acceptable to live kidney donor and recipient transplant patients. It will also look at the impact of prehabilitation on post operative outcomes. The main questions it aims to answer are: Is it feasible for renal transplant patients and live kidney donors to participate in a prehabilitation programme in combination with a piece of wearable technology? Are transplant outcomes improved by prehabilitation regimens delivered by video instruction? Are there discernible perioperative digital signatures provided by the wearable that link to surgical outcomes? Is the quality of perioperative sleep linked to surgical outcomes? Participants will: Wear a wrist or ring worn wearable device for a total of 14 weeks (2 week baseline, 6 week pre op and 6 week post op) Engage in a 6 week pre operative exercise programme at home/gym Keep a diary and answer surveys on their experience of the exercise regimen and wearable device
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2025
CompletedFirst Posted
Study publicly available on registry
March 5, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
March 25, 2025
March 1, 2025
1.1 years
February 17, 2025
March 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number days exercise regimen performed and wearable device worn
Acceptability of a prehabiltation programme and wearable device. Is a pre-operative exercise regimen, monitored by a wearable smart device acceptable to live kidney donor and recipient transplant patients? Qualitative data collected through patient surveys and journals. Quantitative measures = number of days exercise performed \& number of days wearable device worn
From enrollment to the end of the study at 14 weeks total
Secondary Outcomes (3)
Number of participants with post operative complications
From enrollment to the end of the study at 14 weeks total - complications recorded at 6 week post op follow up
REM Sleep pattern analysis
From enrollment to the end of the study at 14 weeks total when data collection ends
Resting heart rate and heart rate variability
From enrollment to the end of the study at 14 weeks total when data collection ends
Study Arms (1)
Entire cohort
EXPERIMENTALAll participants (both transplant donor and recipients) will be assigned a 6 week graded pre operative outpatient exercise regimen (prehabilitation) delivered by video instruction. Participants will also be monitored 24/7 by a wearable smart device for a total 14 week period (2 week baseline data collection, 6 weeks during prehabilitation and 6 weeks post op).
Interventions
6 week pre-operative graded prehabilitation programme, delivered by video and performed by participant up to 4 times a week at home or in a gym setting
Participants will wear a wearable smart device (wrist or ring worn) for a period for 14 weeks; 2 weeks prior to prehabilitation, 6 weeks during pre-operative prehabilitation and 6 weeks post operative monitoring,
Eligibility Criteria
You may qualify if:
- Aged 18 years and over
- Live kidney donor or transplant recipient
You may not qualify if:
- Deceased donor transplant recipient
- Patient unable to wear or tolerate wearable device
- Unstable angina, recent myocardial infarction, recent cerebrovascular accident or new arrythmia
- Patient declines or is unable to participate in the exercise programme
- Lacks capacity to give informed consent to participate in trial
- Non-English speaking
- No access to a smart device to download application
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Manchester Royal Infirmary
Manchester, M13 9WL, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Gareth Kitchen
University of Manchester
- PRINCIPAL INVESTIGATOR
Hussein Khambalia
Manchester University NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Investigator
Study Record Dates
First Submitted
February 17, 2025
First Posted
March 5, 2025
Study Start
May 1, 2025
Primary Completion (Estimated)
May 28, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
March 25, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share